Christoph Bode

Showing 1-8 of 8 articles

Interventions for valvular disease

Clipping within the leaflet: a novel approach to complex mitral regurgitation pathologies

Wengenmayer T, Bode C, Zehender M, Grundmann S

March 20, 2019 | 10.4244/EIJ-D-18-00772

Interventions for valvular disease

Impact of pulmonary hypertension on in-hospital outcome after surgical or transcatheter aortic valve replacement

Gutmann A, Kaier K, Reinecke H, Frankenstein L, Zirlik A, Bothe W, von zur Mühlen C, Zehender M, Reinöhl J, Bode C, Stachon P

September 20, 2017 | 10.4244/EIJ-D-16-00927

Interventions for valvular disease

Triple orifice as a novel strategy in interventional reconstruction of a mitral pseudo cleft

Wengenmayer T, Zhou Q, Bode C, Zehender M

November 20, 2016 | 10.4244/EIJV12I10A212

Interventions for valvular disease

First transfemoral percutaneous edge-to-edge repair of the tricuspid valve using the MitraClip system

Wengenmayer T, Zehender M, Bothe W, Bode C, Grundmann S

April 20, 2016 | 10.4244/EIJV11I13A296

Interventions for valvular disease

Preprocedural planning and implantation of a transcatheter aortic valve without the use of contrast agent

Reinöhl J, Pache G, Ahrens I, Heidt T, Psyrakis D, Latib A, De Marco F, Schröfel H, Beyersdorf F, Zehender M, Bode C, von zur Mühlen C

March 18, 2016 | 10.4244/EIJY15M07_06

4D-cardiac CT and IVUS support stenting of left main compression due to an enlarged pulmonary artery

Heidt T, Buettner H, Loffelhardt N, Minners J, Langer M, Neumann F, Bode C, Pache G

December 20, 2015 | 10.4244/EIJV11I8A185

“Heart Team” decision making in elderly patients with symptomatic aortic valve stenosis who underwent AVR or TAVI – a look behind the curtain. Results of the prospective TAVI Calculation of Costs Trial (TCCT)

Kaier K, Gutmann A, Vach W, Sorg S, Siepe M, von zur Mühlen C, Moser M, Blanke P, Beyersdorf F, Zehender M, Bode C, Reinöhl J

November 20, 2015 | 10.4244/EIJY14M12_06

Impact of stent length on restenosis in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: analysis based on data from the Trial to Assess the Use of the Cypher Stent in Acute Myocardial Infarction Treated with Balloon Angioplasty (TYPHOON)

Rozenman Y, Witzling V, Tamari I, Turkisher V, Kriviski M, Bode C, Henry P, Teiger E, Cebrian A, Stoll H, Spaulding C

June 30, 2009 | 10.4244/EIJV5I2A34

1

Latest news

State of the Art on ViV-TAVI; Transseptal Punctures; Endovascular Closure and TF-TAVI; Percutaneous PVL Closure: Long-Term Outcomes; and more

October 20, 2021

STATE OF THE ART

Valve-in-valve TAVI: a practical overview

Giuseppe Tarantini et al.

October 20, 2021

TAVI in younger (<70 years old) patients: the AMTRAC registry

Guy Witberg et al.

October 22, 2021

Impact of LVOT calcification in transfemoral TAVI patients

L. Waldschmidt et al.

October 19, 2021

My Stroke Story

October 20, 2021

Impact of preprocedural biological markers on 10-year mortality in the SYNTAXES trial

Hironori Hara et al.

October 22, 2021

Serum caffeine causes adenosine-induced FFR overestimation

Hideaki Tanaka et al.

October 15, 2021

Valvular disease